{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:58:35Z","timestamp":1785322715703,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032308","name":"Coalition for Disaster Resilient Infrastructure","doi-asserted-by":"publisher","award":["11071"],"award-info":[{"award-number":["11071"]}],"id":[{"id":"10.13039\/100032308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpet.2025.103765","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:51:02Z","timestamp":1761785462000},"page":"103765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pancreastatin inhibitor PSTi8 alleviates insulin resistance and ovarian dysfunction in a dehydroepiandrosterone\u2013high-fat diet rat model of polycystic ovary syndrome"],"prefix":"10.1016","volume":"392","author":[{"given":"Shubhi","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-320X","authenticated-orcid":false,"given":"Shailesh","family":"Dadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Rathaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debalina","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-2532","authenticated-orcid":false,"given":"V.M.","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7703-9307","authenticated-orcid":false,"given":"Jiaur R.","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su","year":"2025","journal-title":"J Ovarian Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","article-title":"Polycystic ovary syndrome as a metabolic disease","volume":"21","author":"Helvaci","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12902-024-01789-w","article-title":"Obesity is associated with SHBG levels rather than blood lipid profiles in PCOS patients with insulin resistance","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib4","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0342","article-title":"Hormonal changes in PCOS","volume":"261","author":"Yang","year":"2024","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12956\/tchd.1347807","article-title":"The role of the AMH, SHBG, free androgen index and LH\/FSH ratio in the diagnosis of polycystic ovary syndrome in adolescent","volume":"18","author":"B\u00fcy\u00fcky\u0131lmaz","year":"2024","journal-title":"Turk J Pediatr Dis"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00404-024-07897-1","article-title":"Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis","volume":"311","author":"Unfer","year":"2025","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.62110\/sciencein.jist.2024.v12.752","article-title":"Polycystic ovary syndrome (PCOS) and oxidative stress","volume":"12","author":"Sengupta","year":"2024","journal-title":"J Integr Sci Technol"},{"issue":"16","key":"10.1016\/j.jpet.2025.103765_bib8","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.3390\/ijms25169037","article-title":"The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature","volume":"25","author":"Chang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2025.103765_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.31083\/j.ceog5105126","article-title":"Polycystic ovary syndrome (PCOS): symptoms, causes, and treatment","volume":"51","author":"Bai","year":"2024","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103765_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpag.2024.11.003","article-title":"Effect of lifestyle modifications on polycystic ovary syndrome in predominantly young adults: a systematic review","volume":"38","author":"Long","year":"2025","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpet.2025.103765_bib11","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1007\/s12325-025-03251-2","article-title":"Sustained metabolic improvements with low-dose metformin combined with oral contraceptives in female adolescents with PCOS: a single-center retrospective cohort study","author":"Vitale","year":"2025","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib12","article-title":"Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials","volume":"15","author":"Lin","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib13","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1007\/s00210-024-03578-7","article-title":"Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?","volume":"398","author":"Kumbhar","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jpet.2025.103765_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1520695","article-title":"Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential","volume":"12","author":"Yuan","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.jpet.2025.103765_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173204","article-title":"Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice","volume":"881","author":"Gupta","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib16","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1038\/s41598-018-27018-8","article-title":"Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus","volume":"8","author":"Hossain","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103765_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120221","article-title":"Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: in vitro and in vivo findings","volume":"289","author":"Garg","year":"2022","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.jpet.2025.103765_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00726-023-03252-x","article-title":"Chromogranin A-derived peptides pancreastatin and catestatin: emerging therapeutic target for diabetes","volume":"55","author":"Garg","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpet.2025.103765_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170902","article-title":"Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice","volume":"159","author":"Goand","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.jpet.2025.103765_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175559","article-title":"Pancreastatin inhibitor PSTi8 ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production","volume":"944","author":"Garg","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103765_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170147","article-title":"Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT\/GSK-3\u03b2 and PKC\u03bb\/\u03b6\/SREBP1c pathways in high fat diet induced insulin resistance in peri-\/post-menopausal rats","volume":"120","author":"Valicherla","year":"2019","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.jpet.2025.103765_bib22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00726-023-03332-y","article-title":"Pancreastatin inhibitor PSTi8 ameliorates insulin resistance by decreasing fat accumulation and oxidative stress in high-fat diet-fed mice","volume":"55","author":"Garg","year":"2023","journal-title":"Amino Acids"},{"issue":"12","key":"10.1016\/j.jpet.2025.103765_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05826","article-title":"PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1\/SREBP-1c axis","volume":"6","author":"Singh","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jpet.2025.103765_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109558","article-title":"Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters","volume":"214","author":"Yadav","year":"2025","journal-title":"Steroids"},{"key":"10.1016\/j.jpet.2025.103765_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156354","article-title":"Immunometabolic impact of pancreastatin inhibitor PSTi8 in MCD induced mouse model of oxidative stress and steatohepatitis","volume":"171","author":"Goand","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jpet.2025.103765_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109424","article-title":"Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model","volume":"206","author":"He","year":"2024","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.jpet.2025.103765_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch Med Res"},{"issue":"7","key":"10.1016\/j.jpet.2025.103765_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29015","article-title":"A combination of gliclazide and metformin attenuates obesity-induced polycystic ovary syndrome in female Wistar rats","volume":"10","author":"Moazzam","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.jpet.2025.103765_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/molecules27020339","article-title":"Evaluation of the pharmacokinetics of the pancreastatin inhibitor PSTi8 peptide in rats: integration of in vitro and in vivo findings","volume":"27","author":"Valicherla","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103765_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113074","article-title":"LC-ESI-MS\/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: an application to pharmacokinetics","volume":"180","author":"Valicherla","year":"2020","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.jpet.2025.103765_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-291X(02)02565-2","article-title":"Enhanced secretion of glucagon-like peptide 1 by biguanide compounds","volume":"298","author":"Yasuda","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpet.2025.103765_bib32","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.2147\/JIR.S379725","article-title":"Therapeutic effects of silibinin against polycystic ovary syndrome induced by letrozole in rats via its potential anti-inflammatory and anti-oxidant activities","volume":"15","author":"Marouf","year":"2022","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s43032-024-01742-1","article-title":"Improving the dehydroepiandrosterone induced pcos rat model: interplay of age, high fat diet, and treatment regimen on reproductive and metabolic phenotypes","volume":"32","author":"Mallya","year":"2025","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jpet.2025.103765_bib34","series-title":"Specifications for the Conduct of Toxicity Studies by the Division of Translational Toxicology at the National Institute of Environmental Health Sciences [Internet]","article-title":"Fetal examinations and vaginal cytology","author":"Cora","year":"2023"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","article-title":"Determination of malonaldehyde precursor in tissues by thiobarbituric acid test","volume":"86","author":"Mihara","year":"1978","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0031-3955(05)70135-8","article-title":"Menstrual disorders in adolescents: excess androgens and the polycystic ovary syndrome","volume":"46","author":"Gordon","year":"1999","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"10.1016\/j.jpet.2025.103765_bib36","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jpet.2025.103765_bib37","first-page":"707","article-title":"Ovarian follicle atresia: a hormonally controlled apoptotic process","volume":"15","author":"Hsueh","year":"1994","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.jpet.2025.103765_bib38","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jpet.2025.103765_bib39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/me.2013-1233","article-title":"BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells","volume":"27","author":"Chang","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5455\/medarh.2020.74.289-293","article-title":"Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. non-obese women","volume":"74","author":"Saadia","year":"2020","journal-title":"Med Arch"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142241","article-title":"Insulin signaling in health and disease","volume":"131","author":"Saltiel","year":"2021","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103765_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(99)00038-6","article-title":"The role of estrogen in folliculogenesis","volume":"151","author":"Drummond","year":"1999","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib43","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae023","article-title":"Disturbed follicular microenvironment in polycystic ovary syndrome: relationship to oocyte quality and infertility","volume":"165","author":"Dai","year":"2024","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib44","first-page":"5","article-title":"Relationship between polycystic ovary syndrome and metabolic syndrome","volume":"2","author":"Cer\u00f3n","year":"2023","journal-title":"J Reprod"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib45","article-title":"Endocrine and metabolic characteristics in polycystic ovary syndrome","volume":"63","author":"Glintborg","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.jpet.2025.103765_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1030151","article-title":"Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2015.01.019","article-title":"Off-label drug use in the treatment of polycystic ovary syndrome","volume":"103","author":"Vitek","year":"2015","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/biomedicines12030653","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity and treatment with metformin and GLP-1s","volume":"12","author":"Etrusco","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.jpet.2025.103765_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.jpet.2025.103765_bib50","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/clinem\/dgab275","article-title":"Ovarian hyperandrogenism and response to gonadotropin-releasing hormone analogues in primary severe insulin resistance","volume":"106","author":"Huang-Doran","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpet.2025.103765_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111141","article-title":"Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia","volume":"125","author":"Xiang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jpet.2025.103765_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib53","article-title":"Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature","volume":"2022","author":"Xu","year":"2022","journal-title":"J Healthc Eng"},{"key":"10.1016\/j.jpet.2025.103765_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43043-021-00085-0","article-title":"Association of LH\/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome","volume":"26","author":"Mitra\u0161inovi\u0107-Bruli\u0107","year":"2021","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.jpet.2025.103765_bib55","article-title":"Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome","volume":"9","author":"Li","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.jpet.2025.103765_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12640-016-9614-8","article-title":"The effect of chronic mild stress and imipramine on the markers of oxidative stress and antioxidant system in rat liver","volume":"30","author":"Duda","year":"2016","journal-title":"Neurotox Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103765_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J Ovarian Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.jpet.2025.103765_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.jpet.2025.103765_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104544","article-title":"Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways","volume":"110","author":"Zhang","year":"2020","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:13:14Z","timestamp":1773864794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652540278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S002235652540278X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103765","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreastatin inhibitor PSTi8 alleviates insulin resistance and ovarian dysfunction in a dehydroepiandrosterone\u2013high-fat diet rat model of polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103765"}}